Lucia Huang, Co-founder and CEO of Osmind, is transforming mental health care with her tech-driven approach to psychiatry. She discusses the challenges and promises of measurement-based care, including the integration of emerging therapies like ketamine and Spravato. Huang shares her vision for a future where precision medicine enhances treatment decisions, explores the role of biomarkers, and highlights the importance of supporting clinicians amid evolving mental health landscapes. Her insights reflect a hopeful direction in neuropsychiatry.
